OLMESARTAN MEDOXOMIL and HYDROCHLOROTHIAZIDE (olmesartan medoxomil and hydrochlorothiazide) — NDC 43547-392 by Solco Healthcare US
OLMESARTAN MEDOXOMIL and HYDROCHLOROTHIAZIDE (olmesartan medoxomil and hydrochlorothiazide) — NDC 43547-392 by Solco Healthcare US is one of 9,000 drug products in the NDCLookup dataset. Key details — Brand name: OLMESARTAN MEDOXOMIL and HYDROCHLOROTHIAZIDE; Generic name: olmesartan medoxomil and hydrochlorothiazide; P
| Brand name | OLMESARTAN MEDOXOMIL and HYDROCHLOROTHIAZIDE |
|---|---|
| Generic name | olmesartan medoxomil and hydrochlorothiazide |
| Product NDC | 43547-392 |
| Labeler | Solco Healthcare US, LLC |
| Dosage form | TABLET |
| Route | ORAL |
| Active ingredients | HYDROCHLOROTHIAZIDE 12.5 mg/1; OLMESARTAN MEDOXOMIL 40 mg/1 |
| Pharmacologic class | Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS] |
| Marketing category | ANDA |
| Product type | HUMAN PRESCRIPTION DRUG |
| Source | openFDA NDC Directory |
$899/mo
Try NDCLookup →